Some rare cancers resist traditional treatments. For metastatic melanoma, standard chemotherapy is often ineffective, so patients are treated with immunotherapy, typically delivered by IV or injection, which can significantly extend survival. In this research spotlight, clinical pharmacist Shawna Kraft discusses using immunotherapy to care for patients with complex cancer needs.
